Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9692619Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$12.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#303
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $12.2M in linked award amounts across 4 award records · Award-linked rank #303.
FY2025 award records by amount
NIH award records listing Genoveffa Franchini as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC012025-05ZIAPhase I HIV vaccine trial with DNAALVAC-HIV gp120 delta V1 vaccines$7.4Maward amount
- $3.5Maward amount
- 1ZIABC012211-01ZIAEssential Logistic Needs to Implement the C.L.E.A.R. Phase-I HIV Vaccine Trial$880.3Kaward amount
- 1ZIABC005645-36ZIARole of the HTLV-1A and HTLV1-C inflammatory profile in disease$342.9Kaward amount
Award organization
Organizations that administered FY2025 awards listing Genoveffa Franchini as a PI.
FY2025 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardDivision of Basic Sciences - Nci
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025$10M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #303
- 2025Entered Top 25% NationallyRanked #303
- 2025Entered Top 10% NationallyRanked #303
- 2025Entered Top 5% NationallyRanked #303